COMP <GO>
OFIX vs EMBC // DIVIDEND YIELD & FCF PAYOUT SAFETY
Orthofix Medical Inc. (NASDAQ) VS. Embecta Corp. (NASDAQ) • 15-METRIC TALLY: OFIX 3
— EMBC 5
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: EMBC
LAST: $10.24 (+1.99%) • MKT CAP: $417.1M
dividend-safety
0.00%
LAST: $6.56 (+1.55%) • MKT CAP: $371.7M
dividend-safety
9.42%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OFIX VS. EMBC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OFIX | EMBC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 68.80% | 62.60% | +6.20 | OFIX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -12.20% | 35.50% | -47.70 | EMBC | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 6.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 7.99% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -9.90% | 22.40% | -32.30 | EMBC | /operating-margins <GO> |
| Net Profit Margin | -11.20% | 8.80% | -20.00 | EMBC | /net-margins <GO> |
| Revenue Growth (YoY) | 2.90% | -3.80% | +6.70 | OFIX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 9.42% | -9.42 | EMBC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.02 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.3 | 52.2 | -9.89 | EMBC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 3.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $417.1M | $371.7M | $45.4M | OFIX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OFIX REV | EMBC REV | OFIX GROSS % | EMBC GROSS % | OFIX FCF | EMBC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $822.3M | $1.08B | 68.8% | 62.6% | $33.3M | $182.4M |
| FY 2024 | $799.5M | $1.12B | 68.3% | 65.5% | $25.8M | $19.9M |
| FY 2023 | $746.6M | $1.12B | — | — | -$45.8M | $67.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OFIX // BETA —
EMBC // BETA —